“…These alterations include mutations of the TP53 genes (Mashiyama et al, 1991), homozygous deletion of the INK4A/MTS1 and INK4B/MTS2 genes (Kamb et al, 1994), inactivation of the PTEN1 gene Steck et al, 1997), ampli®cation of the EGFR, MDM2, PDGFR, CDK4 and/or cyclin D3 genes (He et al, 1994;Hunter et al, 1995;Kumabe et al, 1992;Sonoda et al, 1995b;Kuchiki et al, 2000) as well as frequent loss of chromosomal loci on 9p, 10, 11q, 13q, 17p, 19q, and 22q (Fults et al, 1990;Collins and James, 1993;Lang et al, 1994;Sonoda et al, 1995aSonoda et al, , 1996.…”